Skip to main content
Clinical Trials/NCT00148408
NCT00148408CompletedPhase 4

Trial of Asthma Patient Education (TAPE)

American Lung Association Asthma Clinical Research Centers39 sites in 1 country600 target enrollmentStarted: December 1, 2003Last updated:
Conditions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Completed
Sponsor
Enrollment
600
Locations
39
Primary Endpoint
Morning peak expiratory flow

Study Overview

Brief Summary

The purpose of this research study is to investigate the way that educational approaches and presentation of a drug may affect the response to montelukast and placebo (an inactive medication) in subjects with asthma.

Detailed Description

This is a study of the effects of education and drug presentation on efficacy of montelukast and placebo in asthma. This trial will answer the following questions: 1) Is there a true placebo response in asthma that is not due to non-specific factors? 2) Can the placebo effect in asthma be augmented by interventions that increase expectancy of benefit? 3) Can interventions that increase expectancy augment the effect of active treatment? 4) Are placebo effects additive or interactive with treatment effects?

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Factorial
Masking
Double

Eligibility Criteria

Ages
15 Years to — (Child, Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • age 15 or older
  • physician diagnosed asthma
  • regular use of prescribed asthma medication over preceding year
  • post-bronchodilator FEV1 of at least 75% of predicted
  • inadequate asthma control over preceding two months

Exclusion Criteria

  • current or past smoking (greater than 10 pack-years)
  • serious asthma exacerbation within previous three months
  • regular use of oral corticosteroids
  • history of respiratory failure due to asthma
  • current use of montelukast or history of adverse reaction to montelukast
  • concomitant interfering medical condition
  • participation in another clinical trial
  • inability or unwillingness to perform study procedures
  • pregnancy, lack of effective contraception (when appropriate), lactation

Outcomes

Primary Outcomes

Morning peak expiratory flow

Secondary Outcomes

  • Asthma diaries
  • Spirometry
  • Asthma questionnaires (Asthma Control Score, Asthma Symptom Utility Index, Asthma Quality of Life)
  • Generic health quality of life (SF-36)
  • Shortness of Breath Questionnaire
  • Adherence monitoring

Investigators

Sponsor
American Lung Association Asthma Clinical Research Centers
Sponsor Class
Other

Study Sites (39)

Loading locations...

Similar Trials

Trial of Asthma Patient Education (TAPE) | Clinical Trial